JP2005504059A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504059A5
JP2005504059A5 JP2003523246A JP2003523246A JP2005504059A5 JP 2005504059 A5 JP2005504059 A5 JP 2005504059A5 JP 2003523246 A JP2003523246 A JP 2003523246A JP 2003523246 A JP2003523246 A JP 2003523246A JP 2005504059 A5 JP2005504059 A5 JP 2005504059A5
Authority
JP
Japan
Prior art keywords
azabicyclo
hept
benzamide
yloxy
ylsulfanyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003523246A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504059A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/021327 external-priority patent/WO2003018586A1/en
Publication of JP2005504059A publication Critical patent/JP2005504059A/ja
Publication of JP2005504059A5 publication Critical patent/JP2005504059A5/ja
Withdrawn legal-status Critical Current

Links

JP2003523246A 2001-08-24 2002-08-14 疾患を処置するための置換アリール7−アザ[2.2.1]ビシクロヘプタン Withdrawn JP2005504059A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US31486201P 2001-08-24 2001-08-24
US31477101P 2001-08-24 2001-08-24
US31476901P 2001-08-24 2001-08-24
US31476701P 2001-08-24 2001-08-24
US38910902P 2002-06-14 2002-06-14
PCT/US2002/021327 WO2003018586A1 (en) 2001-08-24 2002-08-14 Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of disease

Publications (2)

Publication Number Publication Date
JP2005504059A JP2005504059A (ja) 2005-02-10
JP2005504059A5 true JP2005504059A5 (cg-RX-API-DMAC7.html) 2006-01-12

Family

ID=27540992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003523246A Withdrawn JP2005504059A (ja) 2001-08-24 2002-08-14 疾患を処置するための置換アリール7−アザ[2.2.1]ビシクロヘプタン

Country Status (7)

Country Link
US (1) US20030069296A1 (cg-RX-API-DMAC7.html)
EP (1) EP1419162A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005504059A (cg-RX-API-DMAC7.html)
BR (1) BR0212123A (cg-RX-API-DMAC7.html)
CA (1) CA2455773A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04000779A (cg-RX-API-DMAC7.html)
WO (1) WO2003018586A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269413A1 (en) * 2002-11-01 2004-05-25 Pharmacia & Upjohn Company Llc Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy
EP1687004A4 (en) 2003-11-10 2009-04-08 Synta Pharmaceuticals Corp PYRIDINE COMPOUNDS
US8188277B2 (en) 2004-08-06 2012-05-29 Otsuka Pharmaceutical Co., Ltd. Aromatic compounds for suppressing the generation of collagen
GB0424564D0 (en) * 2004-11-05 2004-12-08 Novartis Ag Organic compounds
EP1957073B1 (en) 2005-12-05 2014-04-23 Otsuka Pharmaceutical Co., Ltd. Medicinal drug
UA95978C2 (ru) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
ES2627221T3 (es) 2006-12-28 2017-07-27 Rigel Pharmaceuticals, Inc. Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
EP2231600B1 (en) 2007-11-16 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
EP2231666B1 (en) 2007-12-12 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
WO2009132136A1 (en) 2008-04-23 2009-10-29 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
HUE026815T2 (en) 2008-11-19 2016-07-28 Forum Pharmaceuticals Inc Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
CN103189377B (zh) 2010-10-29 2015-02-25 辉瑞大药厂 N1/n2-内酰胺乙酰辅酶a羧化酶抑制剂

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3702324A (en) * 1970-06-24 1972-11-07 Stanford Research Inst 3,4,5-trimethoxybenzamides of substituted anilines and of alkylpiperidines
NL7611713A (nl) * 1975-11-03 1977-05-05 Thomae Gmbh Dr K Werkwijze voor de bereiding van verbindingen en preparaten met waardevolle farmacologische eigen- schappen.
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
US4593034A (en) * 1984-04-06 1986-06-03 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
US4870181A (en) * 1985-02-04 1989-09-26 A. H. Robins Company, Incorporated Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2])octan-3-yl)aminobenzamides
EP0385517B1 (en) * 1985-03-14 1993-04-14 BEECHAM GROUP plc Medicaments for the treatment of emesis
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
US4717563A (en) * 1986-03-05 1988-01-05 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
ES2051753T3 (es) * 1986-12-16 1994-07-01 Robins Co Inc A H N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.
US5237066A (en) * 1987-02-04 1993-08-17 Delande S.A. Enantiomers of absolute configuration S of amide derivatives of 3-aminoquinuclidine, the process for preparing them and their application in therapy
US4835162A (en) * 1987-02-12 1989-05-30 Abood Leo G Agonists and antagonists to nicotine as smoking deterents
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
US5206246A (en) * 1987-10-16 1993-04-27 A. H. Robins Company, Incorporated Anxiolytic-R-n(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides
IE63474B1 (en) * 1987-12-24 1995-04-19 Wyeth John & Brother Ltd Heterocyclic compounds
EP0353371A1 (en) * 1988-08-04 1990-02-07 Synthelabo Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides
ATE85217T1 (de) * 1988-08-04 1993-02-15 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.>oct-3-yl)benzamide und thiobenzamide.
US5290938A (en) * 1989-09-15 1994-03-01 Chiron Laboratories A.S. Preparation of S-(-)- and R-(+)-N-(quinuclidinyl-3)-amide
US5057519A (en) * 1990-06-11 1991-10-15 Bristol-Myers Squibb Company 5-HT3 antagonists: use in reducing opiate tolerance
US5070095A (en) * 1990-12-12 1991-12-03 A. H. Robins Company, Incorporated Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- and -4-amine as gastric prokinetic, antiemetic, and anxiolytic agents
US5084460A (en) * 1990-12-24 1992-01-28 A. H. Robins Company, Incorporated Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides
ES2149767T5 (es) * 1991-09-20 2005-06-16 Glaxo Group Limited Nuevo uso medico para antagonistas de taquiquininas.
US5273972A (en) * 1992-03-26 1993-12-28 A. H. Robins Company, Incorporated [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
US5977144A (en) * 1992-08-31 1999-11-02 University Of Florida Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
US6060473A (en) * 1993-04-01 2000-05-09 Ucb S.A. - Dtb 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
IL109451A0 (en) * 1993-04-29 1994-07-31 Zeneca Ltd Heterocyclic derivatives
US6117889A (en) * 1994-04-01 2000-09-12 University Of Virginia 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
US5510486A (en) * 1994-07-26 1996-04-23 Syntex (U.S.A.) Inc. Process for preparing 2-(1-azabicyclo 2.2.2!oct-3-yl)-2,3,3A,4,5,6-hexahydro-1H-benz de!isoquinolin-1-one
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
US5741819A (en) * 1995-06-07 1998-04-21 3-Dimensional Pharmaceuticals, Inc. Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
BR0212101A (pt) * 2001-08-24 2004-08-24 Pharmacia & Up John Company 7-aza [2.2.1] biciclo-heptanos substituìdos com heteroarila para o tratamento de doenças
MXPA04007083A (es) * 2002-02-20 2004-10-29 Upjohn Co Compuestos azabiciclicos para el tratamiento de enfermedades.

Similar Documents

Publication Publication Date Title
US10544146B2 (en) Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US20110288063A1 (en) Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
JP2004504404A5 (cg-RX-API-DMAC7.html)
RU2006138433A (ru) Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2
AU2002359164A8 (en) Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
CA2537127A1 (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
IE921366A1 (en) New dialkylenepiperidino compounds and their enantiomers,¹process for preparing them and pharmaceutical compositions¹containing them
KR960014125A (ko) 헤테로사이클 화합물, 이들의 제조방법 및 용도
CA2284732A1 (en) Analogs of cocaine
CA2472149A1 (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
TW200528440A (en) 2-cyanopyrrolidinecarboxamide compound
AU2013262320A1 (en) High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
JP2008525464A5 (cg-RX-API-DMAC7.html)
EA009941B1 (ru) Имидазопиридинзамещённые тропановые производные, обладающие активностью антагониста ccr5 рецептора, для лечения вируса иммунодефицита человека (вич) и воспаления
CA2545092A1 (en) Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
JPS58198490A (ja) 化学的化合物
CN100436414C (zh) 作为毒蕈碱受体拮抗剂的氮杂双环衍生物
JP2004175809A (ja) 哺乳動物における嗜癖性障害および神経障害または精神障害の治療用医薬組成物
KR880013897A (ko) 약리학적 활성을 가진 치환 벤즈아미드
KR20240099451A (ko) Ripk1 억제제로서의 이속사졸리딘 및 이의 용도
US7514450B2 (en) Azabicyclic aryl derivatives
MXPA04007936A (es) Compuestos de aril-sustituidos para el tratamiento de enfermedades.
JP2023552838A5 (cg-RX-API-DMAC7.html)
JPH05507942A (ja) 新規セロトニン作動性剤としての新規なmeso―アザ環式芳香族酸アミド化合物およびエステル化合物
JP2005504059A (ja) 疾患を処置するための置換アリール7−アザ[2.2.1]ビシクロヘプタン